| Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire. | |
| | |
MedLine Citation:
|
PMID: 8594686 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Resistance of Plasmodium falciparum to available antimalarial drugs is now thought to be spreading progressively throughout sub-Sahara Africa. In this study we measured the susceptibility of P. falciparum to chloroquine and pyrimethamine-sulfadoxine in vivo in Rwandan patients living in Kibumba refugee camp in Goma, Zaire. Of the 39 cases treated with chloroquine, only 8 (20.5%) showed sensitive or RI (delayed) response and 31 (79.5%) demonstrated resistance at RI (30.8%), RII (33.3%( and RIII (15.4%) levels. Of the 38 individuals receiving pyrimethamine-sulfadoxine, 13 (34.2%) showed sensitive or RI (delayed) responses, and 25 (65.%) showed resistance at RI (26.3%), RII (36.8%) and RIII (2.6%) levels. Both chloroquine and pyrimethamine-sulfadoxine reduced parasite counts by at least 75% in the majority of the patients within 2 d of treatment. A greater proportion of children with malnutrition showed a higher mean geometric parasite density and slower parasite clearance in vivo than those without malnutrition. Moreover, the frequency and degree of resistance were more pronounced in children with malnutrition. Moreover, the frequency and degree of resistance were more pronounced in children with malnutrition. The results suggest the existence of resistance to chloroquine and pyrimethamine-sulfadoxine. However, the drugs are still effective in significantly reducing parasitaemia and they can still be used as drugs of first and second choice in the region, even in the face of some degree of resistance. |
| | |
Authors:
|
D Wolday; T Kibreab; D Bukenya; R Hodes |
Related Documents
:
|
10890136 - A blinded, controlled trial of an ultrasound device as mosquito repellent. 18959166 - Two new species of perichaena (myxomycetes) from arid areas of russia and kazakhstan. 11797176 - Prevention of malaria in children. 6632036 - Failure to participate in a malaria chemosuppression programme: north mara, tanzania. 6989856 - Enterotoxigenic escherichia coli in central canada. 11109696 - Substance use by indigenous and non-indigenous primary school students. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Transactions of the Royal Society of Tropical Medicine and Hygiene Volume: 89 ISSN: 0035-9203 ISO Abbreviation: Trans. R. Soc. Trop. Med. Hyg. Publication Date: 1995 Nov-Dec |
Date Detail:
|
Created Date: 1996-04-08 Completed Date: 1996-04-08 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7506129 Medline TA: Trans R Soc Trop Med Hyg Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 654-6 Citation Subset: IM |
Affiliation:
|
American Joint Distribution Committee, Goma, Zaire. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Animals Antimalarials / therapeutic use* Child Child, Preschool Chloroquine / therapeutic use Democratic Republic of the Congo / epidemiology Drug Combinations Drug Resistance Female Humans Infant Malaria, Falciparum / drug therapy*, epidemiology, ethnology Male Middle Aged Nutritional Status Plasmodium falciparum / drug effects* Pyrimethamine / therapeutic use Refugees* Rwanda / ethnology Sulfadoxine / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Antimalarials; 0/Drug Combinations; 2447-57-6/Sulfadoxine; 54-05-7/Chloroquine; 58-14-0/Pyrimethamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and tre...
Next Document: Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated ...